Yes, you can take cilostazol daily—it is specifically designed for continuous daily use.
Cilostazol is indicated for daily administration at 100 mg twice daily (morning and evening) for the treatment of intermittent claudication in patients with peripheral arterial disease (PAD), provided you do not have heart failure 1, 2, 3, 4.
Dosing and Administration
The standard regimen is:
- 100 mg orally twice daily (most effective dose)
- Taken continuously, not as-needed
- Can be reduced to 50 mg twice daily if side effects occur
- Treatment duration in clinical trials ranged from 12-24 weeks, with benefits appearing as early as 2-4 weeks 1, 4
The drug is designed for chronic daily use—this is not an "as-needed" medication. Five prospective randomized trials demonstrated that cilostazol improves maximal walking distance by 40-60% compared to placebo after 12-24 weeks of continuous daily therapy 1.
Critical Contraindication
Cilostazol is absolutely contraindicated in patients with heart failure of any severity 3. The FDA has mandated a black-box warning because other phosphodiesterase type 3 inhibitors (like milrinone and vesnarinone) are associated with increased mortality in heart failure patients 1. Even though cilostazol trials showed similar cardiovascular death rates (0.6% vs 0.5% placebo over 6 months), the contraindication remains absolute due to the drug class effect 1.
Expected Benefits with Daily Use
When taken daily as prescribed:
- Walking distance: Increases pain-free walking distance and maximal walking distance significantly 1, 5
- Quality of life: Meta-analyses show improvements in walking ability and health-related quality of life 1, 3
- Symptom onset: Benefits typically appear within 2-4 weeks, with full effect by 12-24 weeks 4
- Additional benefits: May reduce restenosis after femoropopliteal endovascular interventions 3
Common Side Effects to Anticipate
With daily use, expect these potential adverse effects (occurring in approximately 10-20% of patients):
- Headache (most common—occurs 2-3 times more often than placebo) 1, 2, 3
- Diarrhea
- Abnormal stools
- Palpitations
- Dizziness 1
Important clinical pearl: About 20% of patients discontinue cilostazol within 3 months due to side effects 3. Therefore, assess tolerance at 2-4 weeks and evaluate benefit at 3-6 months to determine if long-term daily therapy is worthwhile for you.
Long-term Safety with Daily Use
The CASTLE study followed 1,435 patients taking cilostazol daily for up to 36 months 6:
- No increase in all-cause mortality (hazard ratio 0.94)
- No increase in cardiovascular mortality
- No increase in serious bleeding events, even when combined with aspirin or anticoagulants
- Most patients had poor long-term adherence (>60% discontinued by 36 months), primarily due to side effects rather than safety concerns
Monitoring Recommendations
When taking cilostazol daily:
- Initial assessment: Evaluate tolerance at 2-4 weeks
- Efficacy check: Assess walking distance improvement at 3-6 months
- Continue if beneficial: If you experience meaningful improvement in claudication symptoms and tolerate the medication, continue indefinitely
- Discontinue if: No benefit after 3-6 months or intolerable side effects
Comparison to Alternatives
Cilostazol is superior to pentoxifylline (the only other FDA-approved medication for claudication), which has marginal and poorly established efficacy 1, 2. The 2024 ACC/AHA guidelines give cilostazol a Class I recommendation (strongest level) while pentoxifylline receives a Class III: No Benefit recommendation 3.
Bottom line: Daily cilostazol is the gold-standard pharmacologic therapy for intermittent claudication, taken continuously at 100 mg twice daily, unless you have heart failure (absolute contraindication) or cannot tolerate the side effects (particularly headache).